학술논문
Brazilian Society of Rheumatology 2020 guidelines for psoriatic arthritis
Document Type
article
Author
Carneiro, Sueli; Palominos, Penelope Esther; Anti, Sônia Maria Alvarenga; Assad, Rodrigo Luppino; Gonçalves, Rafaela Silva Guimarães; Chiereghin, Adriano; Lyrio, Andre Marun; Ximenes, Antônio Carlos; Saad, Carla Gonçalves; Gonçalves, Célio Roberto; Kohem, Charles Lubianca; Marques, Cláudia Diniz Lopes; Schainberg, Cláudia Goldenstein; Meirelles, Eduardo de Souza; Resende, Gustavo Gomes; Pieruccetti, Lenise Brandao; Keiserman, Mauro Waldemar; Yazbek, Michel Alexandre; Sampaio-Barros, Percival Degrava; Lage, Ricardo da Cruz; Bonfiglioli, Rubens; Oliveira, Thauana Luíza; Azevedo, Valderílio Feijó; Bianchi, Washington Alves; Bernardo, Wanderley Marques; Simões, Ricardo dos Santos; Pinheiro, Marcelo de Medeiros; Campanholo, Cristiano Barbosa
Source
Advances in Rheumatology. January 2021 61
Subject
Language
English
ISSN
2523-3106
Abstract
Psoriatic arthritis (PsA) is a chronic and systemic immune disease characterized by inflammation of peripheral and/ or axial joints and entheses in patients with psoriasis (PsO). Extra-articular and extracutaneous manifestations and numerous comorbidities can also be present. These recommendations replace the previous version published in May 2013. A systematic review of the literature retrieved 191 articles that were used to formulate 12 recommendations in response to 12 clinical questions, divided into 4 sections: diagnosis, non-pharmacological treatment, conventional drug therapy and biologic therapy. These guidelines provide evidence-based information on the clinical management for PsA patients. For each recommendation, the level of evidence (highest available), degree of strength (Oxford) and degree of expert agreement (interrater reliability) are reported.